Field Notes, powered by KPMG, is a weekly news update on news nationally and globally from the agri-food sector.
The US Food and Drug Administration (FDA) approved an intentional genomic alteration (IGA) in a line of domestic pigs, referred to as GalSafe pigs. The IGA is intended to eliminate alpha-gal sugar on the surface of the pigs' cells in order to reduce the allergic reactions from people with Alpha-gal syndrome when consuming red meat. This is a first-of-its-kind IGA approved by the FDA for the purpose of food consumption and as a source for potential therapeutic uses.
© 2021 KPMG, a New Zealand Partnership and a member firm of the KPMG global organisation of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. All rights reserved.
For more detail about the structure of the KPMG global organization please visit https://home.kpmg/governance.